RTW Biotech Opportunities Ltd
RTWFF
$1.20
$0.010.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 2.66M | 2.66M | 1.44M | 1.44M | 1.14M |
| Total Revenue | 2.66M | 2.66M | 1.44M | 1.44M | 1.14M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 2.66M | 2.66M | 1.44M | 1.44M | 1.14M |
| SG&A Expenses | 3.07M | 3.07M | 2.58M | 2.58M | 1.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.33M | 3.33M | 2.75M | 2.75M | 1.83M |
| Operating Income | -668.80K | -668.80K | -1.32M | -1.32M | -683.80K |
| Income Before Tax | -25.82M | -25.82M | 42.91M | 42.91M | 25.35M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.82M | -25.82M | 42.91M | 42.91M | 25.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.82M | -25.82M | 42.91M | 42.91M | 25.35M |
| EBIT | -668.80K | -668.80K | -1.32M | -1.32M | -683.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.08 | -0.08 | 0.13 | 0.13 | 0.12 |
| Normalized Basic EPS | -0.02 | -0.02 | 0.06 | 0.06 | -0.02 |
| EPS Diluted | -0.08 | -0.08 | 0.13 | 0.13 | 0.12 |
| Normalized Diluted EPS | -0.02 | -0.02 | 0.06 | 0.06 | -0.02 |
| Average Basic Shares Outstanding | 335.71M | 335.71M | 335.71M | 335.71M | 210.64M |
| Average Diluted Shares Outstanding | 335.71M | 335.71M | 335.71M | 335.71M | 210.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |